Angiopoietin-2 drives lymphatic metastasis of pancreatic cancer

Item Type:	Article
Title:	Angiopoietin-2 drives lymphatic metastasis of pancreatic cancer
Creators Name:	Schulz, P. and Fischer, C. and Detjen, K.M. and Rieke, S. and Hilfenhaus, G. and von Marschall, Z. and Boehmig, M. and Koch, I. and Kehrberger, J. and Hauff, P. and Thierauch, K.H. and Alves, F. and Wiedenmann, B. and Scholz, A.
Abstract:	Lymphatic metastasis constitutes a critical route of disease dissemination, which limits the prognosis of patients with pancreatic ductal adenocarcinoma (PDAC). As lymphangiogenesis has been implicated in stimulation of lymphatic metastasis by vascular endothelial growth factor-C (VEGF-C) and VEGF-D, we studied the effect of the angioregulatory growth factor angiopoietin-2 (Ang-2) on PDAC progression. Ang-2 was found to be expressed in transformed cells of human PDAC specimens, with corresponding Tie-2 receptors present on blood and lymphatic endothelium. In vitro in PDAC cells, Ang-2 was subject to autocrine/paracrine TGF-β stimulation (2-fold induction, P=0.0106) acting on the -61- to +476-bp element of the human Ang-2 promoter. In turn, Ang-2 regulated the expression of genes involved in cell motility and tumor suppression. Orthotopic PDAC xenografts with forced expression of Ang-2, but not Ang-1, displayed increased blood and lymphatic vessel density, and an enhanced rate of lymphatic metastasis (6.7- to 9.1-fold, P<0.01), which was prevented by sequestration of Ang-2 via coexpression of soluble Tie-2. Notably, elevated circulating Ang-2 in patients with PDAC correlated with the extent of lymphatic metastasis. Furthermore, median survival was reduced from 28.4 to 7.7 mo in patients with circulating Ang-2 ≥ 75th percentile (P=0.0005). These findings indicate that Ang-2 participates in the control of lymphatic metastasis, constitutes a noninvasive prognostic biomarker, and may provide an accessible therapeutic target in PDAC.
Keywords:	Lymphangiogenesis, Animal Model, Orthotopic, Animals, Mice
Source:	FASEB Journal
ISSN:	0892-6638
Publisher:	Federation of American Societies for Experimental Biology
Volume:	25
Number:	10
Page Range:	3325-3335
Date:	October 2011
Official Publication:	https://doi.org/10.1096/fj.11-182287
PubMed:	View item in PubMed

Repository Staff Only: item control page